Biotech

All Articles

Gene publisher Volume laying off 131 workers

.Simply times after gene editor Volume Biosciences introduced unrevealed functional cuts, a clearer ...

Repare lays off 25% of team as biotech halts preclinical R&ampD

.Repare Therapy is giving up a quarter of its own staff as the oncology biotech downsize its preclin...

J &amp J files for FDA confirmation of $6.5 B autoimmune medication

.Johnson &amp Johnson has actually gotten another step towards understanding a gain on its own $6.5 ...

Gain's phase 1 gain paves way to verify Parkinson's medicine's worth

.Gain Therapies has actually specified its direct verifying the performance of its Parkinson's healt...

Actinogen reports brand new stage 2 data to save anxiety medication

.Actinogen Medical's chances-- and stock price-- have actually recoiled slightly from previously thi...

Pfizer and Flagship add Quotient to multibillion-dollar equation

.Crown Jewel Pioneering and also Pfizer have added Ratio in to their 10-program partnership, inking ...

Bayer pens $547M contract to push limits of noncoding RNA

.Bayer execs were actually interested to anxiety to Brutal this summer that the German pharma giant'...

UK unveils programs to launch 18 brand-new medical trial centers

.Surrounded by a yearslong scientific test decline in the U.K., a brand-new public-private alliance ...

UPDATE: Genentech telegrams 93 discharges in California after discussing plannings to shutter cancer immunology research study unit

.Observing the announcement of a sizable discharge round in April and also a primary restructuring e...

Neurocrine's KarXT competitor reaches in phase 2-- yet merely at low dosage

.Neurocrine Biosciences has actually obtained its hoped-for account in a period 2 schizophrenia tria...